IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica

Bibliografiska uppgifter
Huvudupphovsmän:	Jacob, S, Leite, M, Jarius, S, Viegas, S, Cossins, J, Beeson, D, Morgan, B, Vincent, A
Materialtyp:	Conference item
Publicerad:	2007

Liknande verk

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
av: Jacob, S, et al.
Publicerad: (2008)

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
av: Leite, M, et al.
Publicerad: (2008)

Myasthenia Gravis and Neuromyelitis Optica Association
av: J Gordon Millichap
Publicerad: (2012-06-01)

Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
av: Zhen Wang, et al.
Publicerad: (2017-12-01)

NMO-IgG in the diagnosis of neuromyelitis optica.
av: Jarius, S, et al.
Publicerad: (2007)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
av: Jarius, S, et al.
Publicerad: (2007)

Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis
av: Jarius, S, et al.
Publicerad: (2007)

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.
av: Leite, M, et al.
Publicerad: (2012)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
av: Jarius, S, et al.
Publicerad: (2007)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
av: Jarius, S, et al.
Publicerad: (2007)

Antibodies to AChRs in seronegative myasthenia gravis
av: Leite, M, et al.
Publicerad: (2006)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters
av: Koneczny, I, et al.
Publicerad: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
av: Koneczny, I, et al.
Publicerad: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
av: Inga Koneczny, et al.
Publicerad: (2013-01-01)

Clinical and immunological correlates in myasthenia gravis associated with musk antibodies
av: Viegas, S, et al.
Publicerad: (2008)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
av: Saadoun, S, et al.
Publicerad: (2013)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
av: Akman-Demir, G, et al.
Publicerad: (2008)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
av: Tianjiao Duan, et al.
Publicerad: (2018-10-01)

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
av: Saadoun, S, et al.
Publicerad: (2013)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
av: Littleton, E, et al.
Publicerad: (2006)

Antibodies to clustered acetylcholine receptor and thymic changes in seronegative myasthenia gravis
av: Leite, M, et al.
Publicerad: (2007)

Role of complement in myasthenia gravis
av: Pyae Phyo San, et al.
Publicerad: (2023-10-01)

Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation.
av: Spreadbury, I, et al.
Publicerad: (2005)

Myasthenia gravis seronegative for acetylcholine receptor antibodies.
av: Vincent, A, et al.
Publicerad: (2008)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
av: Waters, P, et al.
Publicerad: (2008)

Sequential voltage-gated potassium channel and aquaporin-4 antibodies in a patient with seropositive myasthenia gravis, limbic encephalitis and neuromyelitis optica
av: Jacobson, L, et al.
Publicerad: (2008)

PATHOGENIC MECHANISMS UNDERLYING MYASTHENIA GRAVIS ASSOCIATED WITH MUSK ANTIBODIES
av: Viegas, S, et al.
Publicerad: (2009)

Seroprevalence of Neuromyelitis Optica-IgG of Childhood Compared to Adults
av: J Gordon Millichap
Publicerad: (2008-02-01)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
av: Narayanan Unni, et al.
Publicerad: (2013-01-01)

Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
av: Vincent, A, et al.
Publicerad: (2012)

Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review
av: Xiaoqian Song, et al.
Publicerad: (2025-01-01)

Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
av: Jacob, S, et al.
Publicerad: (2012)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
av: Tianjiao Duan, et al.
Publicerad: (2019-07-01)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
av: Jarius, S, et al.
Publicerad: (2008)

Complement activation in patients with neuromyelitis optica
av: Nytrova, P, et al.
Publicerad: (2014)

Complement activation in patients with neuromyelitis optica.
av: Nytrova, P, et al.
Publicerad: (2014)

Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica.
av: Norio Chihara, et al.
Publicerad: (2013-01-01)

Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder
av: Eun Bin Cho, et al.
Publicerad: (2024-03-01)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
av: Saadoun, S, et al.
Publicerad: (2013)

Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
av: Niks, E, et al.
Publicerad: (2008)